Ujjawal Girdhar

MBBS doctor with 5 years of clinical experience and focused exposure to Pharmacovigilance and Drug Safety. Skilled in adverse event (AE) and serious adverse event (SAE) identification, causality assessment, clinical safety documentation, and regulatory-compliant reporting. Seeking an entry-level role in Pharmacovigilance / Drug Safety with emphasis on patient safety, data quality, and compliance.

Resident Doctor at Kalyani Hospital (2021-03 – Present)

Clinical practice with focus on adverse drug reaction identification and safety documentation

• Identified, assessed, and documented adverse drug reactions (ADRs) during routine clinical practice and follow-ups.
• Performed preliminary drug–event causality assessments and supported escalation of serious or unexpected reactions.
• Reviewed medication histories to identify potential drug interactions and safety concerns.
• Maintained accurate, timely, and regulatory-compliant clinical documentation to support patient safety.

Rotational Intern at ESIC Govt. Medical College & Hospital (2020-01 – 2021-02)

Multi-departmental clinical rotation with exposure to adverse event documentation and safety reporting

• Assisted in identification and documentation of treatment-emergent adverse events across multiple clinical departments.
• Supported pharmacotherapy monitoring and patient safety reporting during inpatient and outpatient care.
• Gained hands-on exposure to safety documentation, reporting standards, and interdepartmental coordination.

Sub-Investigator at COVAXIN Phase III Clinical Trial

Clinical trial safety surveillance and monitoring

• Participated in safety surveillance including adverse event and serious adverse event monitoring.
• Supported follow-up of reported AEs/SAEs and maintenance of subject safety records.
• Assisted in GCP-compliant documentation and adherence to trial safety protocols.

MBBS in Medicine – ESIC Government Medical College & Hospital (2019)